Early Immune-Related Adverse Events Under PD-1/PD-L1 Inhibitors Predict Better Progression-Free Survival in NSCLC

Affiliation auteurs!!!! Error affiliation !!!!
TitreEarly Immune-Related Adverse Events Under PD-1/PD-L1 Inhibitors Predict Better Progression-Free Survival in NSCLC
Type de publicationJournal Article
Year of Publication2019
AuteursBoussageon M., Ortiz-Cuaran S., Chabaud S., Perol D., Avrillon V., Mastroianni B., Fayette J., Ghiringhelli F., Neidhardt E., Swalduz A., Paulus V., Kaderbhai C., Fumet J., Saintigny P., Perol M.
JournalJOURNAL OF THORACIC ONCOLOGY
Volume14
PaginationS407
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN1556-0864
Mots-clésadvanced non-small-cell lung cancer, Adverse event, immune checkpoint blocker
DOI10.1016/j.jtho.2019.08.831